doi: 10.1038/s41573-018-0008-x
GLP-1 receptor agonists can help treat obesity and promote weight loss by slowing gastric emptying, making you feel fuller longer, and also slowing the release of glucose into your bloodstream
Similarly, individuals who have a history of gastrointestinal issues may want to avoid Mounjaro. Smith added that you should talk with your doctor about your medical history to determine which drug may be better for you
But seeing it with a blockbuster obesity drug adds layers of complexity to an already intricate story
Hair thinning can appear around months 4 to 6, driven by the telogen effluvium response to rapid weight loss rather than the medication itself
[63] [51] Clinical trials and early approvals for diabetes [edit] In June 2008, a phase II clinical trial began studying semaglutide, a once-weekly diabetes therapy as a longer-acting alternative to liraglutide